Public notice: Guideline Development Group Meeting on nucleic acid amplification tests (NAATs) for detection of TB and DR-TB

Overview

The World Health Organization (WHO) Global TB Programme (GTB) would like to announce an upcoming Guideline Development Group meeting on the use of NAATs for detection of TB and drug resistance, to be held 6-10 May 2024 in the WHO headquarters in Geneva, Switzerland. 

The WHO assessment process for TB diagnostics currently focuses on evaluating classes of TB diagnostic technologies rather than specific products. However, several individual technologies-based recommendations exist. The objectives of the current update are the following:

• Consolidate individual technologies-oriented recommendations into class-based recommendations;
• Update existing recommendations for technologies falling into above mentioned classes;
• Evaluate parallel use of currently WHO recommended rapid diagnostic tests for diagnosis of TB in children and PLHIV.